Aspire Pharma (H.I.G.-backed) Acquires Morningside Healthcare and Morningside Pharmaceuticals

H.I.G. Capital Acquires Aspire Pharma Limited

September 24, 2021

Pharmaceuticals

An affiliate of H.I.G. Capital has acquired Aspire Pharma Limited, a UK-based developer and licensor of niche generic and branded specialty pharmaceuticals. Founder Graham Fraser-Pye remains with the business as chairman; financial terms were not disclosed and H.I.G. said it will support Aspire's organic growth, M&A activity and international expansion.

Questel Acquires Morningside

March 24, 2021

Professional Services

Questel has acquired Morningside, a New York–headquartered provider of patent translation, foreign filing, and IP language services. The deal expands Questel’s end-to-end IP offering and strengthens its position in patent translation and global law-firm and corporate client coverage.

H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals

December 13, 2021

Pharmaceuticals

An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.

Platinum Equity Acquires Sunrise Medical from Nordic Capital

October 16, 2024

Medical Devices

Platinum Equity has signed a definitive agreement to acquire Sunrise Medical Group, a Germany-headquartered global manufacturer and distributor of assistive mobility products, from Nordic Capital. The buyout (expected to close in Q3 2024) positions Platinum to pursue a buy-and-build strategy to expand Sunrise's geographic footprint—particularly in North America—and to accelerate product and operational investments.

H.I.G. Capital Acquires ITH Group Limited

June 13, 2025

Healthcare Services

H.I.G. Capital (via an affiliate) has completed the acquisition of ITH Group Limited, a UK-based provider of aseptic pharmaceutical compounding services. Financial terms were not disclosed; ITH's founders Adam Bloom and Karen Hamling will remain in management as H.I.G. supports organic growth and increased production capacity.

Lupin Healthcare Acquires Renascience Pharma Limited (UK)

April 2, 2025

Pharmaceuticals

Lupin Healthcare (UK) Limited, a wholly owned subsidiary of Lupin Limited, has acquired UK-based Renascience Pharma Limited, the sole supplier of four specialty branded products in the UK. The acquisition (reported at approximately £12.3 million) expands Lupin's branded specialty portfolio in the UK and strengthens its supply offerings to the NHS across infectious disease, ENT and cardiology/renal indications.